scispace - formally typeset
P

Peter Chiba

Researcher at Medical University of Vienna

Publications -  65
Citations -  1901

Peter Chiba is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: ATP-binding cassette transporter & Transmembrane domain. The author has an hindex of 25, co-authored 65 publications receiving 1717 citations. Previous affiliations of Peter Chiba include University of Vienna.

Papers
More filters
Journal ArticleDOI

P-glycoprotein substrate binding domains are located at the transmembrane domain/transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach.

TL;DR: A set of propafenonetype substrate photoaffinity ligands has been used in this study in conjunction with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to define the substrate binding domain(s) of P-gp in more detail, and binding at domain interfaces may be a general feature of polyspecific drug efflux pumps.
Journal ArticleDOI

Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.

TL;DR: This review will mainly focus on MDR-associated proteins, as well as various nanoparticle formulations developed to overcome MDR in breast cancer.
Journal ArticleDOI

Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis

TL;DR: Mass cultures of primary murine erythroid progenitors from fetal liver suggest that highly efficient utilization of iron in mitochondrial heme synthesis during normal erythropoiesis alters the regulation of iron metabolism via the IRE/IRP system.
Journal ArticleDOI

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).

TL;DR: KP772 is hyperactive in MDR cells and might have chemosensitizing properties by blocking ABCB1 expression, and the data suggest that KP772 should be especially active against notoriously drug-resistant tumor types and as second line treatment after standard chemotherapy failure.
Journal ArticleDOI

Structure–Activity Relationships, Ligand Efficiency, and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors of the Multidrug Transporter P-Glycoprotein

TL;DR: Docking studies of selected analogues into a homology model of P-glycoprotein suggest that benzophenones show an interaction pattern similar to that previously identified for propafenone-type inhibitors.